A double-edged sword: antibody-mediated procoagulant platelets in COVID-19

References

• Helms J, Tacquard C, Severac F, Leonard-Lorant I, Ohana M, Delabranche X, Merdji H, Clere-Jehl R, Schenck M, Fagot Gandet F, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med 2020 May;4:1–10. DOI:https://doi.org/10.1007/s00134-020-06062-x
   Google Scholar
• Malas MB, Naazie IN, Elsayed N, Mathlouthi A, Marmor R, Clary B. Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: a systematic review and meta-analysis. EClinicalMedicine 2020;29:100639. DOI:https://doi.org/10.1016/j.eclinm.2020.100639
   PubMedGoogle Scholar
• Boonyawat K, Chantrathammachart P, Numthavaj P, Nanthatanti N, Phusanti S, Phuphuakrat A, Niparuck P, Angchaisuksiri P. Incidence of thromboembolism in patients with COVID-19: a systematic review and meta-analysis. Thrombosis J 2020;18(1):34. DOI:https://doi.org/10.1186/s12959-020-00248-5
   PubMed Web of Science ®Google Scholar
• Althaus K, Marini I, Zlamal J, Pelzl L, Singh A, Häberle H, Mehrländer M, Hammer S, Schulze H, Bitzer M, et al. Antibody-induced procoagulant platelets in severe COVID-19 infection. Blood 2021;137(8):1061–1071. DOI:https://doi.org/10.1182/blood.2020008762
   PubMed Web of Science ®Google Scholar
• Millington-Burgess SL, Harper MT. Cytosolic and mitochondrial Ca2+ signaling in procoagulant platelets. Platelets 2021 Feb;18:1–8. DOI:https://doi.org/10.1080/09537104.2021.1881951
   Google Scholar
• Nazy I, Jevtic SD, Moore JC, Huynh A, Smith JW, Kelton JG, Arnold DM. Platelet-activating immune complexes identified in critically Ill COVID-19 patients suspected of heparin-induced thrombocytopenia. J Thrombosis Haemostasis: JTH 2021 Feb 27. DOI:https://doi.org/10.1111/jth.15283
   Google Scholar
• Patel P, Michael JV, Naik UP, McKenzie SE. Platelet FcγRIIA in immunity and thrombosis: adaptive immunothrombosis. J Thrombosis Haemostasis [accessed 2021 Mar 12].
   Web of Science ®Google Scholar
• Bhattacharjee S, Banerjee M. Immune thrombocytopenia secondary to COVID-19: a systematic review. Sn Compr Clin Med 2020 Sep;19:1–11. DOI:https://doi.org/10.1007/s42399-020-00521-8
   Google Scholar
• Qiao J, Al‐Tamimi M, Baker RI, Andrews RK, Gardiner EE. The platelet Fc receptor, FcγRIIa. Immunol Rev 2015;268(1):241–252. DOI:https://doi.org/10.1111/imr.12370
   PubMed Web of Science ®Google Scholar
• Washington University School of Medicine. A pilot study of duvelisib to combat COVID-19. clinicaltrials.gov; 2021. Report No.: NCT04372602. https://clinicaltrials.gov/ct2/show/NCT04372602
   Google Scholar
• National Heart, Lung, and Blood Institute (NHLBI). A phase II study evaluating fostamatinib for hospitalized adults with COVID-19. clinicaltrials.gov; 2021. Report No.: NCT04579393. https://clinicaltrials.gov/ct2/show/NCT04579393
   Google Scholar
• Seok J, Warren HS, Cuenca AG, Mindrinos MN, Baker HV, Xu W, Richards DR, McDonald-Smith GP, Gao H, Hennessy L, et al. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A 2013;110(9):3507–3512. DOI:https://doi.org/10.1073/pnas.1222878110
   PubMed Web of Science ®Google Scholar
• Gillis C, Gouel-Chéron A, Jönsson F, Bruhns P. Contribution of human FcγRs to disease with evidence from human polymorphisms and transgenic animal studies. Front Immunol 2014;5:254. DOI:https://doi.org/10.3389/fimmu.2014.00254
   PubMed Web of Science ®Google Scholar
• Larsen MD, De Graaf EL, Sonneveld ME, Plomp HR, Nouta J, Hoepel W, H-j C, Linty F, Visser R, Brinkhaus M, et al. Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity. Science 2021;371(6532):eabc8378. [[accessed 2021Mar24]. https://science.sciencemag.org/content/371/6532/eabc8378
   PubMed Web of Science ®Google Scholar
• Petrović T, Alves I, Bugada D, Pascual J, Vučković F, Skelin A, Gaifem J, Villar-Garcia J, Vicente MM, Fernandes Â, et al. Composition of the immunoglobulin G glycome associates with the severity of COVID-19. Glycobiology 2020;cwaa102. [[accessed 2021 Mar 24]. DOI:https://doi.org/10.1093/glycob/cwaa102
   Google Scholar
• Schoenwaelder SM, Yuan Y, Josefsson EC, White MJ, Yao Y, Mason KD, O’Reilly LA, Henley KJ, Ono A, Hsiao S, et al. Two distinct pathways regulate platelet phosphatidylserine exposure and procoagulant function. Blood 2009;114(3):663–666. DOI:https://doi.org/10.1182/blood-2009-01-200345
   PubMed Web of Science ®Google Scholar
• Abbasian, Millington-Burgess SL, Chaba S, Malcor J-D, Harper MT. Supramaximal calcium signalling triggers procoagulant platelet formation. 2019.
   Google Scholar
• Wei H, Harper MT. ABT-737 triggers caspase-dependent inhibition of platelet procoagulant extracellular vesicle release during apoptosis and secondary necrosis in vitro. Thrombosis Haemostasis 2019;119(10):1665–1674. DOI:https://doi.org/10.1055/s-0039-1693694
   PubMed Web of Science ®Google Scholar
• NaveenKumar SK, SharathBabu BN, Hemshekhar M, Kemparaju K, Girish KS, Mugesh G. The role of reactive oxygen species and ferroptosis in heme-mediated activation of human platelets. ACS Chem Biol 2018;13(8):1996–2002. DOI:https://doi.org/10.1021/acschembio.8b00458
   PubMed Web of Science ®Google Scholar
• Wang S, Liu Y, Li G, Feng Q, Hou M, Peng J. Reduced intracellular antioxidant capacity in platelets contributes to primary immune thrombocytopenia via ROS-NLRP3-caspase-1 pathway. Thrombosis Res 2021;199:1–9. DOI:https://doi.org/10.1016/j.thromres.2020.12.008
   PubMed Web of Science ®Google Scholar
• Vishalakshi GJ, Hemshekhar M, Sandesha VD, Prashanth KS, Jagadish S, Paul M, Kemparaju K, Girish KS. Bisphenol AF elevates procoagulant platelets by inducing necroptosis via RIPK1-inflammasome axis. Toxicology 2021 Mar;1:152742. DOI:https://doi.org/10.1016/j.tox.2021.152742
   Web of Science ®Google Scholar
• Lippi G, Plebani M, Henry BM. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis. Clin Chim Acta 2020;506:145–148. DOI:https://doi.org/10.1016/j.cca.2020.03.022
   PubMed Web of Science ®Google Scholar
• Goeijenbier M, Van Wissen M, Van De Weg C, Jong E, Gerdes VEA, Meijers JCM, Brandjes DPM, Van Gorp ECM. Review: viral infections and mechanisms of thrombosis and bleeding. J Med Virol 2012;84(10):1680–1696. DOI:https://doi.org/10.1002/jmv.23354
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zeng X, Jiao Y, Li Z, Liu Q, Ye J, Yang M. Mechanisms involved in the development of thrombocytopenia in patients with COVID-19. Thrombosis Res 2020;193:110–115. DOI:https://doi.org/10.1016/j.thromres.2020.06.008
   PubMed Web of Science ®Google Scholar
• Wool GD, Miller JL. The impact of COVID-19 disease on platelets and coagulation. Pathobiology 2020 Oct;13:1–13. DOI:https://doi.org/10.1159/000512007
   Google Scholar
• Vogel G, Kupferschmidt K. Data concerns and safety worries fuel crisis of confidence in AstraZeneca vaccine. Science | AAAS 2021 Mar 23- [2021 Mar 23 [accessed 2021 Mar 26]. https://www.sciencemag.org/news/2021/03/data-concerns-and-safety-worries-fuel-crisis-confidence-astrazeneca-vaccine
   Google Scholar
• CoViD vaccines and thrombotic events: possibility of mRNA translation and spike protein synthesis by platelets? 2021 Mar;15:n699.
   Google Scholar
• Greinacher A, Thiele T, Warkentin TE, Weisser K, Kyrle P, Eichinger S. A Prothrombotic Thrombocytopenic Disorder Resembling Heparin-Induced Thrombocytopenia Following Coronavirus-19 Vaccination. Research Square. 2021. https://www.researchsquare.com/article/rs-362354/v1. DOI:https://doi.org/10.21203/rs.3.rs-362354/v1
   Google Scholar
• Perricone C, Ceccarelli F, Nesher G, Borella E, Odeh Q, Conti F, Shoenfeld Y, Valesini G. Immune thrombocytopenic purpura (ITP) associated with vaccinations: a review of reported cases. Immunol Res 2014;60(2):226–235. DOI:https://doi.org/10.1007/s12026-014-8597-x
   PubMed Web of Science ®Google Scholar